Invention Grant
US09309231B2 Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof
有权
桥连环化合物作为丙型肝炎病毒(HCV)抑制剂及其药物应用
- Patent Title: Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof
- Patent Title (中): 桥连环化合物作为丙型肝炎病毒(HCV)抑制剂及其药物应用
-
Application No.: US14397200Application Date: 2013-08-05
-
Publication No.: US09309231B2Publication Date: 2016-04-12
- Inventor: Yingjun Zhang , Jiancun Zhang , Hongming Xie , Qingyun Ren , Yumei Tan , Huichao Luo
- Applicant: SUNSHINE LAKE PHARMA CO., LTD
- Applicant Address: CN Dongguan, Guangdong
- Assignee: Sunshine Lake Pharma Co., Ltd.
- Current Assignee: Sunshine Lake Pharma Co., Ltd.
- Current Assignee Address: CN Dongguan, Guangdong
- Agency: Squire Patton Boggs (US) LLP
- Agent Kam W. Law
- Priority: CN201210273491 20120803; CN201310116933 20130403
- International Application: PCT/CN2013/000915 WO 20130805
- International Announcement: WO2014/019344 WO 20140206
- Main IPC: A61K31/4178
- IPC: A61K31/4178 ; C07D403/14 ; C07D401/14 ; C07D413/14 ; C07D409/14 ; C07D417/14 ; C07D453/06 ; C07D471/08 ; C07D491/056 ; C07D493/08 ; C07D519/00 ; A61K31/4184 ; A61K31/427 ; A61K31/439 ; A61K31/4545 ; A61K31/5377 ; A61K45/06 ; C07D491/113 ; C07D405/14

Abstract:
Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder.
Public/Granted literature
- US20150079028A1 Bridged Ring compounds As Hepatitis C Virus (HCV) Inhibitors And Pharmaceutical Applications Thereof Public/Granted day:2015-03-19
Information query
IPC分类: